Eyeworld Supplements

EWAP SUM 2018 - Sponsored by Ivantis

This is a supplement to EyeWorld Magazine.

Issue link: http://supplements.eyeworld.org/i/979289

Contents of this Issue

Navigation

Page 0 of 7

Sponsored by Ivantis The news magazine of the Asia-Pacific Association of Cataract & Refractive Surgeons APACRS Asia-Pacific Supplement to EyeWorld Asia-Pacific Summer 2018 The Hydrus Microstent: Australian perspectives on outcomes up to 3 years from more than 500 eyes in a clinical registry with all its attendant benefits and risks. Such a risk/bene- fit profile is different from canal-based procedures such as the Hydrus Microstent or indeed suprachoroidal procedures. Terminology that differentiates these may be required. Moderator: That's an interest- ing observation. The differ- ences you note will likely be raised again later when we discuss the technology in more detail. this new paradigm in glauco- ma treatment, often referred to as microinvasive glaucoma surgery (MIGS), will be of considerable interest to your colleagues worldwide. Dr. Healey: It's worth pointing out that MIGS is a convenient term, but not very specific. Perhaps it is time to search for another. A short tube put through the wall of the eye may be considered MIGS, but such procedures must always be treated as a type of external drainage procedure, your thoughts regarding the use and efficacy of the Hydrus Microstent in your practices. The panel in this room is arguably one of the most ex- perienced groups in the world regarding the length of time you've used the device and the volume of surgeries com- pleted with the device, either in combination with cataract surgery or as a standalone procedure. Your insights will be helpful to surgeons around the world as they obtain access to the Hydrus Micro- stent. I know any advances in Notes from a surgeon roundtable discussion Moderator: I want to thank you all for taking the time to meet with me here in Brisbane, Australia. As you know, I am interested in your experiences with the Hydrus Microstent, the Schlemm's canal scaffold from Ivantis (Irvine, Califor- nia). I would like to begin by sharing some data collected from Ivantis' global online registry. That will be our starting point, but more im- portantly, I'd like you to share The panel Mark Chiang, MBBS, FRANZCO Dr. Chiang is an ophthalmic consultant in private practice and at the Royal Brisbane and Women's Hospital in Brisbane, Austra- lia, where he specializes in glaucoma and cataract surgery. Brendan Cronin, MBBS, DipOphthSci, BCom, LLB, FRANZCO Dr. Cronin is the lead corneal and anterior segment surgeon and the director of education at the Queensland Eye Institute in Brisbane, Australia. Matthew Green, BAppSc(Optom), MSc, MBBS, FRANZCO Dr. Green is a Queensland-trained optometrist and ophthalmologist with subspecialty training in corneal, cataract, and refractive surgery. He is in private practice in Tweed Heads, Australia. Graham Hay-Smith, MA, ACFA(UK), MBBS, MRCS(Ed), FRCOphth, FRANZCO Dr. Hay-Smith is an experienced oph- thalmic and cataract surgeon in private practice in Brisbane, Australia, who specializes in retinal diseases and uveitis. Clinical Associate Professor Paul Healey, B(Med)Sc, MBBS, MMed, PhD, FRANZCO Dr. Healey is the director of glaucoma services at Westmead Hospital and consultant glaucoma surgeon at Sydney Eye Hospital. He is clinical associate professor at Sydney Medical School, Sydney University. Associate Professor Graham Lee, MBBS, FRANZCO Dr. Lee is an ophthalmic consultant in pri- vate practice in Brisbane, Australia, where he specializes in cataract surgery and the advanced management of primary and complex glaucoma. Ridia Lim, MBBS, MPH, FRANZCO Dr. Lim is a cataract and glaucoma specialist in private practice in Sydney, Australia and a consultant glaucoma surgeon at Sydney Eye Hospital. Joshua Yuen, MBBS, MPH, FRANZCO Dr. Yuen is a consultant ophthalmic sur- geon in private practice in Perth, Australia, specializing in the medical and surgical treatment of glaucoma. Clinical Associate Professor Andrew White, BMedSc, MBBS, PhD, FRANZCO Dr. White is a clinician scientist ophthal- mologist at Westmead Hospital and is in private practice in Sydney, Australia. He has a subspecialty interest in glaucoma. Richard Potvin, MASc, OD Dr. Potvin is a third-party ophthalmic research consultant, providing data analysis, technical support and medical writing services to eyecare professionals and the eyecare industry. Moderator continued on page 2

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - EWAP SUM 2018 - Sponsored by Ivantis